PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24421218-9	2013	RESULTS: Infusion of sulodexide caused acute and transient peak of the Hepatocyte Growth Factor (HGF) concentration in blood and decrease of the Vascular Endothelial Growth Factor (VEGF) level, what, as we found in in vitro experiments, was due to adsorption of VEGF to endothelium.	glucuronyl glucosamine glycan sulfate	21-31	hepatocyte growth factor	Homo sapiens	71-95	
24421218-9	2013	RESULTS: Infusion of sulodexide caused acute and transient peak of the Hepatocyte Growth Factor (HGF) concentration in blood and decrease of the Vascular Endothelial Growth Factor (VEGF) level, what, as we found in in vitro experiments, was due to adsorption of VEGF to endothelium.	glucuronyl glucosamine glycan sulfate	21-31	hepatocyte growth factor	Homo sapiens	97-100	
17258198-0	2007	Sulodexide induces hepatocyte growth factor release in humans.	glucuronyl glucosamine glycan sulfate	0-10	hepatocyte growth factor	Homo sapiens	19-43	
17258198-2	2007	The effects of sulodexide, a heparin-like glycosaminoglycan medication of growing importance in medicine, on HGF liberation are not known.	glucuronyl glucosamine glycan sulfate	15-25	hepatocyte growth factor	Homo sapiens	109-112	
17258198-7	2007	Intravenous sulodexide injections were repeatedly found to induce marked and reproducible increases in immunoreactive plasma HGF levels (more than 3500% vs baseline after 10 min, and more than 1200% after 120 min), and remained unchanged when measured 120 min following oral sulodexide administration.	glucuronyl glucosamine glycan sulfate	12-22	hepatocyte growth factor	Homo sapiens	125-128	
17258198-12	2007	This study shows that sulodexide has a novel, remarkable and plausibly biologically important stimulating effect on the release of pleiotropic hepatocyte growth factor in humans.	glucuronyl glucosamine glycan sulfate	22-32	hepatocyte growth factor	Homo sapiens	143-167